"We are the headquarters for an integrated network of premier investigational sites conducting clinical research studies. Many of our studies are for paid volunteers. Want to volunteer for a clinical trial? Check out our website to view our current studies in Raleigh, or view one of our other locations in North America to see if you may qualify for a trial. We work closely with and meet the needs of the biopharmaceutical, biotechnology, medical device, pharmaceutical industries and clinical research organizations. Clinical trials allow medical researchers to evaluate drug effectiveness and safety in a controlled environment. Wake Research is dedicated to conducting safe and successful studies."

During the past decade, Wake Research Associates conducted 156 clinical trials. In the 10-year time frame, 156 clinical trials started and 148 clinical trials were completed, i.e. on average, 94.9% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 92 clinical trials were completed. i.e. 187.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wake Research Associates" #1 sponsor was "Pfizer" with 39 trials, followed by "Bausch Health Americas, Inc." with 7 trials sponsored, "Shire" with 7 trials sponsored, "Cephalon" with 6 trials sponsored and "Eli Lilly and Company" with 6 trials sponsored. Other sponsors include 236 different institutions and companies that sponsored additional 165 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wake Research Associates" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Premier Research Group plc" with 3 trials as a collaborator, "Allergan Sales, LLC" with 2 trials as a collaborator, "Elan Pharmaceuticals" with 2 trials as a collaborator and "GlaxoSmithKline" with 2 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Wake Research Associates" are "Atopic Dermatitis" (12 trials), "Crohn's Disease" (11 trials), "Influenza" (8 trials), "Acne Vulgaris" (7 trials) and "Binge Eating Disorder" (7 trials). Many other conditions were trialed in "Wake Research Associates" in a lesser frequency.

Most popular intervention types in "Wake Research Associates" are "Drug" (241 trials), "Biological" (52 trials), "Other" (30 trials), "Device" (11 trials) and "Combination Product" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (121 trials), "placebo" (11 trials), "Vehicle" (7 trials), "Naproxen" (5 trials) and "Midazolam" (4 trials). Other intervention names were less common.

The vast majority of trials in "Wake Research Associates" are 265 trials for "All" genders, 38 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Wake Research Associates". undefined are not yet recruiting, 7 are recruiting, 18 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 243 completed trials in Wake Research Associates, undefined suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in Wake Research Associates, 17 "Phase 1" clinical trials were conducted, 110 "Phase 2" clinical trials and 161 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 14 trials that are defined as “Not Applicable".